Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Editor-in-Chief

Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 7, September

Editorial [Hot topic: Focal Adhesion Kinase Signaling in Cancer- Part II (Guest Editor: Vita M. Golubovskaya)]

Volume:11   Issue: 7
Pp: 591-592
Vita M. Golubovskaya
DOI: 10.2174/187152011796817709
Published on: 01 March, 2012

Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase

Volume:11   Issue: 7
Pp: 593-599
Alexander Schultze and Walter Fiedler
DOI: 10.2174/187152011796817727
Published on: 01 March, 2012

FAK and WNT Signaling: The Meeting of Two Pathways in Cancer and Development

Volume:11   Issue: 7
Pp: 600-606
Yuri Fonar and Dale Frank
DOI: 10.2174/187152011796817673
Published on: 01 March, 2012

Focal Adhesion Kinase Controls Prostate Cancer Progression Via Intrinsic Kinase and Scaffolding Functions

Volume:11   Issue: 7
Pp: 607-616
Sheila Figel and Irwin H. Gelman
DOI: 10.2174/187152011796817646
Published on: 01 March, 2012

FAK and p53 Protein Interactions

Volume:11   Issue: 7
Pp: 617-619
Vita M. Golubovskaya and William G. Cance
DOI: 10.2174/187152011796817619
Published on: 01 March, 2012

Inhibition of Hyaluronan Synthase-3 Decreases Subcutaneous Colon Cancer Growth by Increasing Apoptosis

Volume:11   Issue: 7
Pp: 620-628
Brian P. Teng, Melissa D. Heffler, Eric C. Lai, Ya-Li Zhao, Charles M. LeVea, Vita M. Golubovskaya and Kelli M. BullardDunn
DOI: 10.2174/187152011796817655
Published on: 01 March, 2012

A Novel Small Molecule Inhibitor of FAK and IGF-1R Protein Interactions Decreases Growth of Human Esophageal Carcinoma

Volume:11   Issue: 7
Pp: 629-637
Deniz A. Ucar, Audrey Cox, Di-Hua He, David A. Ostrov, Elena Kurenova and Steven N. Hochwald
DOI: 10.2174/187152011796817718
Published on: 01 March, 2012

Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy

Volume:11   Issue: 7
Pp: 638-642
Wen Wee Ma
DOI: 10.2174/187152011796817628
Published on: 01 March, 2012

Coordinated Expression of Pax-5 and FAK1 in Metastasis

Volume:11   Issue: 7
Pp: 643-649
Nicolas Crapoulet, Pierre O'Brien, Rodney J. Ouellette and Gilles A. Robichaud
DOI: 10.2174/187152011796817637
Published on: 01 March, 2012

Cell Contact/Adhesion Proteins Lgl and DFak56: Tumorigenic and Whole-Organism Vital Effects Studied in Drosophila

Volume:11   Issue: 7
Pp: 650-657
Nataly Ya. Weisman and Michael D. Golubovsky
DOI: 10.2174/187152011796817736
Published on: 01 March, 2012

Recent Developments in the Mechanism of Anticancer Agents Based on Electron Transfer, Reactive Oxygen Species and Oxidative Stress

Volume:11   Issue: 7
Pp: 658-668
Peter Kovacic and Ratnasamy Somanathan
DOI: 10.2174/187152011796817691
Published on: 01 March, 2012

Nanoparticles in Oncology: The New Theragnostic Molecules

Volume:11   Issue: 7
Pp: 669-686
Alessandro Allegra, Giuseppa Penna, Andrea Alonci, Vincenzo Rizzo, Sabina Russo and Caterina Musolino
DOI: 10.2174/187152011796817682
Published on: 01 March, 2012

Nitroimidazoles as Anti-Tumor Agents

Volume:11   Issue: 7
Pp: 687-691
Kai Liu and Hai-Liang Zhu
DOI: 10.2174/187152011796817664
Published on: 01 March, 2012